Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds-Reference-Cited by-同舟云学术

Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

Published:1990-02 Issue:2 Volume:36 Page:207-211
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Gore M.E.,Fryatt I.,Wiltshaw E.,Dawson T.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference11 articles.

1. Use of high dose cis-dichloro-diammine platinum (II) (NSC-119875) following failure on previous chemotherapy for advanced carcinoma of the ovary;Barker;Brit. J. Obstet. Gynecol.,1981

2. Ovarian trials at the Royal Marsden;Wiltshaw;Cancer Treat. Rev.,1985

3. A prospective randomised trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma;Wiltshaw;J. Clin. Oncol.,1986

4. The CHAD and HAD regimens in advanced ovarian cancer. Combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin and cis-dichlorodiammine-platinum (II);Vogl;Cancer Treat. Rep.,1979

5. Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin;Bruckner;Cancer,1981

Cited by 338 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and molecular features of platinum resistance in ovarian cancer;Critical Reviews in Oncology/Hematology;2024-09

2. 5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer;Gynecologic Oncology;2024-03

3. The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients;Cancers;2024-02-02

4. Treatment Approaches for Platinum-Resistant Ovarian Cancer;Journal of Clinical Oncology;2024-01-10

5. The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients;npj Precision Oncology;2023-10-31